FIELD: medicine, cardiology. SUBSTANCE: preparation has the following composition: mixture of aethmosine with aethacizine at their mass ratio = 6: 1. Preferably, preparation has 150 mg aethmosine and 25 mg aethacizine, or 75 mg aethmosine and 12.5 mg aethacizine. Preparation is used for heart rhythm impairment. EFFECT: enhanced effectiveness of preparation. 3 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIARRYTHMIC AGENT | 1983 |
|
RU2068261C1 |
METHOD FOR DETERMINING ELECTROPHYSIOLOGICAL MECHANISMS OF EXTRASYSTOLIA DEVELOPMENT | 1998 |
|
RU2214161C2 |
MEDICINAL SPECIES FOR TREATMENT OF PATIENTS WITH CARDIAC RHYTHM DISORDER | 1994 |
|
RU2088250C1 |
ANTIARRHYTHMIC PREPARATION | 1999 |
|
RU2185159C2 |
METHOD FOR DIAGNOSING ELECTRIC MYOCARDIAL INSTABILITY | 1998 |
|
RU2178983C2 |
METHOD FOR TREATING VENTRICULAR EXTRASYSTOLE | 0 |
|
SU1797910A1 |
METHOD OF ASSAY OF INDIVIDUAL SENSITIVITY IN PATIENTS WITH ISCHEMIC HEART DISEASE TO ANTIANGINAL AND ANTIARRHYTHMIC PREPARATIONS IN LASEROTHERAPY CARRYING OUT | 1998 |
|
RU2141365C1 |
METHOD FOR TREATMENT CARDIAC RHYTHM DAMAGE | 0 |
|
SU1804865A1 |
2-MERCAPTOBENZIMIDAZOLE DERIVATIVES SHOWING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 1995 |
|
RU2136667C1 |
METHOD FOR PREDICTING MECHANISMS OF VENTRICULAR EXTRASYSTOLIA | 2005 |
|
RU2294138C2 |
Authors
Dates
1997-04-10—Published
1993-07-08—Filed